Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT06666673Phase 1Recruiting
Phase 1, randomised, double-blind trial of tizanidine in stroke (2 arms), sponsored by Northwestern University. Primary endpoints: Brace Height, Cortico-muscular-coherence in beta band and 2 more. Started Aug 2024; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT06666673.